Monocacy Therapeutics Inc.

MONROVIA, MD · Founded 2025 · CIK 0002137361 · Biotech · Private

AI-guided immune medicines designed to restore optimal immune function

monocacytx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$389K
4 Form D · Sep 2026
0 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$114,450
Private capital raised· 1 of 2 same dayForm D · SEC$125,000
Private capital raised· 2 of 2 same dayForm D · SEC$150,000
Private capital raisedForm D · SEC$49
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2237LOXIGEN, INC.——
2238KAPHA BIO, INC.——
2239Forecast Bio, Inc.—$2.4M
2240Monocacy Therapeutics Inc.—$389K
2241POWERHOUSE PROTEOMIC SYSTEMS, LLC——
2242TENSIVE CONTROLS, INC.——
2243Acelyrin——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Suman VodnalaDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.